High rate of complete remisions (CR) with concomitant chemoradiotherapy (QRT) in esophageal cancer (EC).: Preliminary results in a phase II trial.

被引：0
|
作者：
Balmana, J
Brunet, J
Balart, J
Rodriguez, MR
Montesinos, J
Rius, X
Gallen, M
Arcusa, A
Pardo, B
Marcuello, E
López, JJL
机构：
[1] Hosp St Pau, Med Oncol Serv, Barcelona, Spain
[2] Hosp St Pau, Serv Radioterapia, Barcelona, Spain
[3] Hosp St Pau, Serv Cirugia, Barcelona, Spain
[4] Hosp Del Mar, Serv Oncol, Barcelona, Spain
[5] Gen Hosp, Terrassa, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [31] Improving bone health in men with prostate cancer on ADT: Results of a randomized phase II trial.
    Alibhai, Shabbir M. H.
    Breunis, Henriette
    Timilshina, Narhari
    Hamidi, Maryam S.
    Tomlinson, George A.
    Manokumar, Tharsika
    Samadi, Osai
    Sandoval, Joanna
    Durbano, Sara
    Cheung, Angela
    Warde, Padraig Richard
    Jones, Jennifer M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Camrelizumab with Chemoradiotherapy for Locally Advanced Biliary Tract Cancer: Preliminary Results from A Phase II Study
    Guo, Q.
    Liu, J.
    Dou, X.
    Zhu, K.
    Shi, P.
    Zhang, Y.
    Li, S.
    Feng, R.
    Yue, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E355 - E355
  • [33] An open label, multicenter clinical study of cetuximab combined with concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma Preliminary results of a phase II trial
    Yu, J. M.
    Wang, J. H.
    Sun, X.
    Wang, L. H.
    Zhu, G. Y.
    Feng, P. B.
    Ye, M.
    Lu, Y.
    Zhu, S. C.
    Liao, Z. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Xu, Yaping
    Ma, Shenglin
    Ji, Yongling
    Sun, Xiaojiang
    Jiang, Hao
    Chen, Jianxiang
    Du, Xianghui
    Zheng, Yuanda
    Qiu, Guoqin
    LUNG CANCER, 2011, 72 (03) : 327 - 332
  • [35] A PHASE-II TRIAL OF PACLITAXEL (TAXOL) IN ADVANCED ESOPHAGEAL CANCER - PRELIMINARY-REPORT
    KELSEN, D
    AJANI, J
    ILSON, D
    DAUGHERTY, K
    PAZDUR, R
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 44 - 48
  • [36] Stereotactic body radiotherapy for high-risk prostate cancer (5 treatment days): Toxicity results of a phase II trial.
    Kishan, Amar Upadhyaya
    Fuller, Donald B.
    Steinberg, Michael L.
    Ramirez, Victoria
    Agazaryan, Nzhde
    Ruan, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [37] High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial
    Yoshioka, Y
    Nose, T
    Yoshida, K
    Inoue, T
    Yamazaki, H
    Tanaka, E
    Shiomi, H
    Imai, A
    Nakamura, S
    Shimamoto, S
    Inoue, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 675 - 681
  • [38] Concurrent Chemoradiotherapy with a Novel Fluoropyrimidine, S-1, and Cisplatin for Locally Advanced Esophageal Cancer: Long-Term Results of a Phase II Trial
    Iwase, Hiroaki
    Shimada, Masaaki
    Tsuzuki, Tomoyuki
    Hirashima, Noboru
    Okeya, Masayuki
    Hibino, Yusuke
    Ryuge, Nobumitsu
    Yokoi, Misaki
    Kida, Yuichi
    Kuno, Takeshi
    Tanaka, Yusaku
    Kato, Bunichiro
    Esaki, Masaya
    Urata, Noboru
    Kato, Eriko
    ONCOLOGY, 2013, 84 (06) : 342 - 349
  • [39] Local Excision After Preoperative Chemoradiotherapy for Rectal Cancer: Results of a Multicenter Phase II Clinical Trial
    Pucciarelli, Salvatore t
    De Paoli, Antonino
    Guerrieri, Mario
    La Torre, Giuseppe
    Maretto, Isacco
    De Marchi, Francesco
    Mantello, Giovanna
    Gambacorta, Maria Antonietta
    Canzonieri, Vincenzo
    Nitti, Donato
    Valentini, Vincenzo
    Coco, Claudio
    DISEASES OF THE COLON & RECTUM, 2013, 56 (12) : 1349 - 1356
  • [40] Successful treatment of chronic refractory idiopathic thrombocytopenic purpura with high dose folic acid. Phase II trial. Preliminary results.
    Schulz, E
    Holanda, RAR
    Saad, STO
    BLOOD, 2003, 102 (11) : 299A - 299A
12345